Opko Health Inc (OPK) Stock Price, Quote & News

Company Profile

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 305 575 4100

Website: www.opko.com

Address:

4400 Biscayne Boulevard, Miami, United States

tymtested Sep. 12 at 5:51 PM

$OPK things may be looking up! CUP N' HANDLE chart.

1 · Reply

Love_To_Learn Sep. 12 at 5:08 PM

$OPK NEED U SHORTLY DUE TO EVERYTHING GOING ON N NVCN * @joka2189

0 · Reply

LongAllDay Sep. 12 at 4:03 PM

$OPK wow did someone see that massive 100 share buy on level 2? bulls are in control and we may see 2000 shares of volume today. thanks frost you are the best ceo you make shareholders so wealthy

1 · Reply

tymtested Sep. 12 at 12:11 PM

$OPK Zack’s articles fail to mention many important aspects of investing in opko… namely Ngenla, insider holdings, institutional holdings, notes, additional indications for Ngenla, etc etc..

1 · Reply

ZacksResearch Sep. 11 at 4:29 PM

$OPK poised for growth, but can it overcome competition? 🏥 RAYALDEE's strong performance and strategic partnerships are driving optimism, yet reliance on a single product and stiff competition remain significant challenges. 🤔 Discover the full outlook for OPKO Health here 👉 https://www.zacks.com/stock/news/2750286/heres-why-you-should-retain-opko-health-stock-in-your-portfolio?cid=sm-stocktwits-2-2750286-body-12060&ADID=SYND_STOCKTWITS_TWEET_2_2750286_BODY_12060

1 · Reply

Mike18181 Sep. 11 at 4:29 PM

$OPK Another great day in NCLH, not bad for a guy who cant pass his GED. Ill go to one of my Key west BRars to celebrate. On my Grady White open fishermen with 2 235 outboards. Opko a great story, 4K score will save the company.🥰

0 · Reply

ZacksResearch Sep. 11 at 3:29 PM

$OPK — reasons to keep holding 📈 RAYALDEE momentum, strategic partnerships, and progressing trials are fueling the case, even with competition and dependence risks in play. Full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2750286/heres-why-you-should-retain-opko-health-stock-in-your-portfolio?cid=sm-stocktwits-2-2750286-teaser-12056&ADID=SYND_STOCKTWITS_TWEET_2_2750286_TEASER_12056

0 · Reply

This_Bull_Is_Retired Sep. 11 at 11:52 AM

$OPK $RATFARTS The only fraud here is you. Find one post where I'm pumping this stock. Unlike you, I only state facts when it comes to Opko. Your post below is an example of someone pumping there short inetrest in OPK. If you hate this stock and MGT Team so much why not walk away and say nothing??? BTW, swing trading has been going on for over 40 years, so there is nothing wrorng with me taking that approach to making money on OPK. Not once have I ever said I'm long on OPK. Get your story right fly boy. Try stating facts and maybe you will get 1 or 2 likes.

1 · Reply

Mike18181 Sep. 10 at 3:30 PM

$OPK Market Capitalization of this company is not in Alignment of the earnings 🤮. Institutional investors DO NOT inventory Garbage under $ 5.00 Per share. The stock is sandbagged and will lay dead !! FDA ,wallstrret, Inveztment houses no longer like Frost. So, let Frost buy all he wants. Frost also goes to the Movie theatre in an empty buildibg, nobody is watching the movie but phil. Nobody wants this as they know the Whole story of Poor Management performance, but Frost know the Pharm industry. Tbats irrelevant to performance of Opko. He should step down at the cash bleeding company." Where you find Disorganization, you will find Evil "

1 · Reply

LongAllDay Sep. 10 at 12:45 PM

$OPK chase savings accounts yielded better returns over last 12 years THANKS FROST FATHER YOU ARE THE REAL MISTER 305

0 · Reply

OPKO Health, Inc. (OPK) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 4:05 PM EDT - 6 weeks ago

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

Jun 30, 2025, 8:01 AM EDT - 2 months ago

NextPlat Issues Interim CEO Update Shareholder Letter

NXPL

Jun 25, 2025, 11:00 AM EDT - 2 months ago

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

May 15, 2025, 8:00 AM EDT - 4 months ago

OPKO Health to Participate in Two Upcoming Investor Conferences

Apr 30, 2025, 7:52 PM EDT - 4 months ago

OPKO Health, Inc. (OPK) Q1 2025 Earnings Call Transcript

Apr 4, 2025, 8:00 AM EDT - 5 months ago

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

Mar 17, 2025, 8:57 AM EDT - 6 months ago

OPKO and Entera partner to develop obesity pill

Mar 11, 2025, 7:00 AM EDT - 6 months ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Feb 27, 2025, 7:12 PM EST - 7 months ago

OPKO Health, Inc. (OPK) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:10 PM EST - 7 months ago

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

Jan 9, 2025, 11:45 AM EST - 8 months ago

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 18, 2024, 8:00 AM EST - 10 months ago

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

NXPL

Nov 14, 2024, 6:00 AM EST - 10 months ago

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

BABA NXPL

Nov 7, 2024, 8:30 PM EST - 11 months ago

OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript

Oct 7, 2024, 8:00 AM EDT - 1 year ago

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

Oct 7, 2024, 8:00 AM EDT - 1 year ago

NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan

NXPL

Sep 16, 2024, 7:30 AM EDT - 1 year ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

Aug 7, 2024, 4:06 PM EDT - 1 year ago

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

Jul 17, 2024, 4:14 PM EDT - 1 year ago

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments

May 31, 2024, 10:48 AM EDT - 1 year ago

OPKO Health to Participate in the Jefferies Global Healthcare Conference

May 7, 2024, 8:03 PM EDT - 1 year ago

OPKO Health, Inc. (OPK) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

May 3, 2024, 8:00 AM EDT - 1 year ago

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 28, 2024, 8:00 AM EDT - 1 year ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Mar 5, 2024, 8:52 AM EST - 1 year ago

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

Feb 27, 2024, 8:08 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 1 year ago

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

Feb 22, 2024, 4:05 PM EST - 1 year ago

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

Jan 9, 2024, 4:05 PM EST - 1 year ago

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser's Option to Purchase Additional Notes

Jan 4, 2024, 11:31 PM EST - 1 year ago

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

Jan 3, 2024, 5:05 PM EST - 1 year ago

OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

Nov 28, 2023, 7:00 AM EST - 1 year ago

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

Nov 7, 2023, 6:45 AM EST - 2 years ago

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

SOPH

Nov 6, 2023, 7:32 PM EST - 2 years ago

OPKO Health, Inc. (OPK) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 4:05 PM EST - 2 years ago

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

Nov 2, 2023, 10:00 AM EDT - 2 years ago

New Clinical Data on OPKO Health's RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

Oct 31, 2023, 8:00 AM EDT - 2 years ago

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

Oct 25, 2023, 4:25 PM EDT - 2 years ago

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

Oct 20, 2023, 1:30 PM EDT - 2 years ago

OPKO Health: FDA Approval To Save The Company

Sep 28, 2023, 4:08 PM EDT - 2 years ago

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

Aug 4, 2023, 12:17 AM EDT - 2 years ago

OPKO Health, Inc. (OPK) Q2 2023 Earnings Call Transcript

Jul 31, 2023, 2:19 PM EDT - 2 years ago

OPKO Health: Improving Profitability Should Drive Shares Forward Post Q2 Earnings

Jul 25, 2023, 4:05 PM EDT - 2 years ago

OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

Jun 28, 2023, 6:45 AM EDT - 2 years ago

FDA Approves Pfizer's NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency

PFE

May 11, 2023, 12:29 PM EDT - 2 years ago

OPKO Health's Future After Merck Deal: Bright Or Uncertain

MRK

May 3, 2023, 8:42 PM EDT - 2 years ago

OPKO Health, Inc. (OPK) Q1 2023 Earnings Call Transcript

May 3, 2023, 4:05 PM EDT - 2 years ago

OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results

Apr 26, 2023, 12:15 AM EDT - 2 years ago

Strong Small-Cap Insider Buys: Q1 2023

AAT ABBV BY CCB CCO CMP ENVX

Apr 25, 2023, 4:05 PM EDT - 2 years ago

OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023

tymtested Sep. 12 at 5:51 PM

$OPK things may be looking up! CUP N' HANDLE chart.

1 · Reply

Love_To_Learn Sep. 12 at 5:08 PM

$OPK NEED U SHORTLY DUE TO EVERYTHING GOING ON N NVCN * @joka2189

0 · Reply

LongAllDay Sep. 12 at 4:03 PM

$OPK wow did someone see that massive 100 share buy on level 2? bulls are in control and we may see 2000 shares of volume today. thanks frost you are the best ceo you make shareholders so wealthy

1 · Reply

tymtested Sep. 12 at 12:11 PM

$OPK Zack’s articles fail to mention many important aspects of investing in opko… namely Ngenla, insider holdings, institutional holdings, notes, additional indications for Ngenla, etc etc..

1 · Reply

ZacksResearch Sep. 11 at 4:29 PM

1 · Reply

Mike18181 Sep. 11 at 4:29 PM

0 · Reply

ZacksResearch Sep. 11 at 3:29 PM

0 · Reply

This_Bull_Is_Retired Sep. 11 at 11:52 AM

1 · Reply

Mike18181 Sep. 10 at 3:30 PM

1 · Reply

LongAllDay Sep. 10 at 12:45 PM

$OPK chase savings accounts yielded better returns over last 12 years THANKS FROST FATHER YOU ARE THE REAL MISTER 305

0 · Reply

Ratsfarts Sep. 10 at 12:25 PM

$OPK this bull seems like a total fraud. Kind of like Frost and friends. Ask yourself why Opko has not sold the rest of BRLI and why they keep telling shareholders that it is going to be profitable. Even if it was profitable it wouldn’t move the needle on this depressed SP. Frost must go. He is not capable if running Opko and Wall Street hates him. This bull is nothing but a pumper to try and make a few cents per share and does not believe for one second that opko is a long term play.

0 · Reply

This_Bull_Is_Retired Sep. 10 at 10:56 AM

$OPK Near-term, the win is optics and optionality: the kind of thing that can improve analyst sentiment and keep OPKO in play as a growth or acquisition story. I'm in hope they do the right thing and pay off the notes with the proceeds from BRL. And then sell more peices of the company.

3 · Reply

tymtested Sep. 9 at 11:53 PM

$OPK some investors just have a pauper’s mentality.

0 · Reply

Mike18181 Sep. 9 at 5:45 PM

$OPK The Truth regarding Opko spending. A viable company has good cashflow, earnings, EPS, retained earnings, follows a budget. They report profits, they find ways to grow the business, now they invest money in R&D. The budget for R&D should be sufficient to take on the development to launch a new Revenue driver. ^ the spending should not cripple the bottom line orvmake the company have to keep borrowing or raising capital. No Budget no stock appreciation after this poor decisions. " Well im going to go to my dishwashers job now and go catch the bus at the corner.🤓

0 · Reply

Sierradude Sep. 9 at 3:36 PM

$OPK Not going to give the shorts the satisfaction, I'll stay until I can get my capital back and not one second more...

0 · Reply

LongAllDay Sep. 9 at 1:30 PM

$OPK crazy they won a trophy for being a top 10 lamest investments of the last 12 years

0 · Reply

Mike18181 Sep. 9 at 3:22 AM

$OPK Opk is a BS operation !

1 · Reply

Mike18181 Sep. 9 at 3:20 AM

$OPK 200,000 shares of a Sinkhole Mike Haharis of Key pharm and Daniel Bell marjeting made frost look good. Ivax Corp, Ricgard Phenniger CFO mafe frost look good. Frost seperated from them look at the result. No Guidance.!! 1.36 Form 4 .. Forget the BS sideshow they have no EPS

0 · Reply

Mike18181 Sep. 8 at 11:09 PM

$OPK Winners UAL in at 74.10 In HD 377.43, NVDA in at 106.90, WGS in at 5.98, 11.40 , 23.77 trimmed the position recently by half. MAR in at 181.06 all winners and if I have losses they never exceed 3% or were out.... What do these above stocks have in common. " earnings and smart capitalization. NCLH in 14.75, 15.00, 16 88 Now Opko, they dont tell shareholders the truth, cant budget, cant predict much as CFO as Frost keeps it all. CEO of a public company should not be allowed to have a controlling intetest that is deemed detrimental to all shareholders. My Vote rules and if the ruler cant manage you are watching a Horror show !!! Bull is retired , Im not im going to try to pass my GED and seek your approval !

0 · Reply

Rain9991 Sep. 8 at 7:53 PM

$OPK going to 10 bucks in AH trading….wake up…d

0 · Reply

tymtested Sep. 8 at 7:26 PM

$OPK would love to see a positive pr on business progress to support this little rally.

0 · Reply

Sierradude Sep. 8 at 2:21 PM

$OPK They're averaging down so they can get off the ship before it sinks Yvonne. This has been dead money for all involved ( accept the shorts of course)for a looooooong time. I just hope their average is higher than mine so I can bail first.

1 · Reply

Market Cap	1.11B
Revenue (ttm)	713.14M
Net Income (ttm)	-53.22M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-7.46%
Debt to Equity Ratio	0.19

Volume	1,512,700
Avg Vol	2,421,712
Day's Range	N/A - N/A
Shares Out	793.78M
Stochastic %K	60%
Beta	1.40
Analysts	Strong Sell
Price Target	$2.65